GRASSILLI, EMANUELA
 Distribuzione geografica
Continente #
AS - Asia 99
NA - Nord America 40
EU - Europa 10
Totale 149
Nazione #
HK - Hong Kong 51
SG - Singapore 42
US - Stati Uniti d'America 40
IT - Italia 3
DE - Germania 2
IL - Israele 2
BE - Belgio 1
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NL - Olanda 1
TM - Turkmenistan 1
Totale 149
Città #
Hong Kong 51
Singapore 17
Los Angeles 7
Ashburn 3
Seattle 3
Milan 2
Piscataway 2
Amsterdam 1
Ashgabat 1
Brussels 1
Frankfurt am Main 1
Haifa 1
New York 1
Nicosia 1
Salt Lake City 1
Santa Clara 1
Sona 1
Tallinn 1
Tel Aviv 1
Vientiane 1
Zurich 1
Totale 99
Nome #
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 12
Methods for determining the sensitivity or resistance of cancer cells to at least one anticancer drug and/or therapeutically active molecule 11
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers 10
BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression 9
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients 8
Influence of Bruton’s Tyrosine Kinase (BTK) on Epithelial–Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC) 8
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study 8
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 8
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution? 8
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors 8
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 8
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis 8
Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy 8
Emerging actionable targets to treat therapy-resistant colorectal cancers 7
Identifying novel actionable targets in colon cancer 7
BTK, the new kid on the (oncology) block? 7
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 7
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 7
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 7
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 7
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 6
Editorial: Targeting Bruton Tyrosine Kinase 6
Totale 175
Categoria #
all - tutte 1.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025175 0 0 0 0 25 71 26 4 48 1 0 0
Totale 175